Tag: SAR003
Meet our CEO in LSX World Congress 2024!
Meet our CEO Mikael Maksimow in the LSX World Congress in London on 29-30 April 2024!
Meet Sartar in ESMO Sarcoma and Rare Cancers Congress 2024
We are excited to attend the ESMO Sarcoma and rare cancers Congress next week in Lugano. We are looking forward to learn the latest scientific advancements, connect with KOLs, engage with patient advocacy groups and network within the industry. Do not hesitate to reach out to our CEO, Mikael Maksimow, if you would like to […]
Rare diseases matter!
International rare disease day! Over 300 million people around the world are living with a rare disease! Then imagine how many of us are affected by rare diseases – whether as patients ourselves, caregivers, family members, or friends. While individually these conditions may affect only a small number of people, collectively they represent a significant portion […]
Meet us in Nordic Life Science days 2023!
Sartar Therapeutics is present in Nordic Life Science Days! Come and meet us or book a meeting during the event! We are looking for Series A funding or co-development partners for our SAR003 treatment for GISt and other soft tissue sarcoma subtypes.
Sartar at CTOS meeting in Dublin
CTOS meeting in Dublin was well organised with highly interesting program. It was great to meet old friends and make new ones. We had very good talks with key opinion leaders, investors and patient advocacy groups.